Physician

Jason N Peter, D.O.

According to 2025 Medicare claims, Jason Peter, D.O. (NPI: 1851581789) practices interventional pain management (ipm) in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Macomb, MI. This provider's primary affiliated billing organization is PAIN CLINIC MANAGEMENT GROUP, PLLC (NPI: 1225302821; TIN: 454023977) and primary practice location at 48309-3607.

Peter's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 485 traditional Medicare patients, billed 3,387 HCPCS/CPT codes, and received $352,694 in Medicare payments. The top billing code was G0482 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 560 prescription claims across 202 beneficiaries totaling $20,440 in drug costs, led by Buprenorphine (Buprenorphine). Open Payments data shows 34 records totaling $1,009. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $670,327 to $20,440. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	431	12,250	$480,397
2016	496	4,747	$323,229
2017	471	3,896	$311,931
2018	382	4,488	$361,777
2019	364	3,503	$325,635
2020	330	4,062	$369,524
2021	329	4,389	$447,720
2022	385	4,024	$386,221
2023	527	3,978	$374,811
2024	485	3,387	$352,694

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	448	6,215	$670,327
2016	542	6,198	$717,942
2017	544	5,597	$460,609
2018	482	4,549	$282,219
2019	439	1,957	$106,294
2020	517	3,603	$218,551
2021	400	1,574	$94,881
2022	360	1,099	$55,391
2023	332	953	$34,454
2024	202	560	$20,440

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	203	378	$195
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	106	106	$124
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	55	85	$110
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	395	1,953	$91
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	84	145	$66

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Buprenorphine	Buprenorphine	22	590	$3,836
Naloxone Hcl	Naloxone Hcl	33	322	$2,029
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	111	2,818	$1,411
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	41	1,153	$686
Pregabalin	Pregabalin	34	1,150	$664

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	34	$1,009	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jason N. Peter, D.O.?

Tedicare shows public-source Medicare data for Jason N. Peter, D.O. (NPI 1851581789), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jason N. Peter, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jason N. Peter, D.O.?

Jason N. Peter, D.O. is linked to PAIN CLINIC MANAGEMENT GROUP, PLLC (billing NPI 1225302821) in the available physician profile data.

Does Jason N. Peter, D.O. have Open Payments data?

Jason N. Peter, D.O. has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.